.
1/2 plate carbs, 1/4 plate non-starchy vegetables, 1/4 plate lean protein
1/2 plate carbs, 1/4 plate healthy fat, 1/4 plate lean protein
1/4 plate carbs, 1/4 plate lean protein, 1/2 plate non-starchy vegetables
1/4 plate lean protein, 1/4 plate healthy fat, 1/2 plate carbs
Patients with type 2 diabetes are covered for 100 strips every 3 months
Patients with diabetes can re‐take the group classes every calendar year with approval from their referring MD
Medicare Part A will cover the costs of Diabetes Self-Management Program
Under Medicare, only group classes are reimbursed
Steroid use induces insulin resistance and affects glucose metabolism, which is manifested especially in post-prandial glucose levels
Steroid use decreases the rate of insulin metabolism and therefore increases the risk for hypoglycemia
Steroid use increases insulin resistance and is specifically manifested in fasting glucose levels
Steroids suppress the immune system and deactivate a portion of both endogenous and exogenous insulin. Therefore, blood glucose typically rises with steroid use
Glucagon is a hormone secreted by the pancreas, which triggers the liver to release glucose stores into the bloodstream
Glucagon is normally administered to an individual with diabetes when they are unconscious in response to hypoglycemia
Individuals with depleted glycogen stores will always respond to a Glucagon injection
Glucagon may be administered through an intravenous, intramuscular or subcutaneous injection
Yes
No
Maybe
Intake of carbohydrate for blood sugar stabilization
Consumption of 15-25 g protein to repair tissue
Intake of dietary fat to prevent hypoglycemia
All of the above
There are some limitations in using A1c as a standard measure of glycemic control in patients with end stage renal disease (ESRD)
Instead of using A1c in patients with ESRD, Glycated Albumin should be ordered to assess for glycemic control
A1c can be increased with the use of erythropoiesisstimulating agents
The accuracy of high performance liquid chromatography in patients with high BUN and Cr is compromised, making the A1c assay inaccurate
Sulfonylureas
Meglitinides
Biguanides
Alpha-glucosidase inhibitors
No, adequate studies have confirmed the safety of rapid-acting insulin during pregnancy
Yes, a change to short-acting insulin would be required because it has been used without associated problems for years
Yes, a change to short-acting and intermediate-acting insulin would be required
No, but the woman would be required to take short-acting insulin with it
Every 3 month
Every 6 months
Once a year
Every 5 years
Weight lifting 3 times per week
Running
Moderate exercise such as walking or water exercises
High intensity spin/cycling class
Quiz Review Timeline +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.